Real-World Treatment Patterns, BRCA Testing Practices, Outcomes, and Health Care Utilization in Platinum-Sensitive Recurrent Serous Ovarian Cancer: A Multi-Country Retrospective Study
Real-World Treatment Patterns, BRCA Testing Practices, Outcomes, and Health Care Utilization in Platinum-Sensitive Recurrent Serous Ovarian Cancer: A Multi-Country Retrospective Study
This study will be carried out as a retrospective, non-interventional observational review of medical records for patients in multiple countries with platinum-sensitive recurrent serous ovarian cancer. The objectives are to describe in a real-world population, treatment patterns, BRCA mutation testing and results, overall survival, health care utilization and also to estimate rates of selected treatment- and/or disease-related side effects
Inclusion Criteria:
Exclusion Criteria:
1. Ever taken an investigational product as part of an interventional clinical trial for ovarian cancer.
Victoria, Australia
Alberta, Canada
Saint Holon, Israel
Franca, Italy
Manerbi, Italy
Ponte A Niccheri, Italy
Santorso VI, Italy
Martinho Do Bispo, Portugal
S. Martinho Do Porto, Portugal
Alzira, Valencia, Spain